IRIS
ETTARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.739
NA - Nord America 4.616
AS - Asia 3.342
SA - Sud America 1.139
AF - Africa 116
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
AN - Antartide 1
Totale 15.959
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.495
RU - Federazione Russa 3.638
SG - Singapore 1.394
BR - Brasile 974
CN - Cina 904
IE - Irlanda 804
IT - Italia 634
SE - Svezia 601
HK - Hong Kong 395
VN - Vietnam 226
DE - Germania 199
FR - Francia 197
GB - Regno Unito 134
PL - Polonia 124
IN - India 106
UA - Ucraina 105
FI - Finlandia 103
AT - Austria 78
BD - Bangladesh 60
CA - Canada 54
AR - Argentina 50
MX - Messico 43
IQ - Iraq 37
TR - Turchia 32
MA - Marocco 30
ZA - Sudafrica 30
ID - Indonesia 28
NL - Olanda 28
BE - Belgio 27
EC - Ecuador 25
UZ - Uzbekistan 22
CO - Colombia 21
JP - Giappone 20
VE - Venezuela 19
ES - Italia 16
PK - Pakistan 16
UY - Uruguay 15
PY - Paraguay 13
SA - Arabia Saudita 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
CL - Cile 10
CZ - Repubblica Ceca 10
DZ - Algeria 8
GE - Georgia 8
MY - Malesia 8
PE - Perù 7
AZ - Azerbaigian 6
CI - Costa d'Avorio 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
PH - Filippine 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EG - Egitto 5
ET - Etiopia 5
IL - Israele 5
JM - Giamaica 5
LB - Libano 5
CH - Svizzera 4
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
NI - Nicaragua 4
SC - Seychelles 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
EU - Europa 3
GR - Grecia 3
KR - Corea 3
KW - Kuwait 3
NP - Nepal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
GA - Gabon 2
HN - Honduras 2
MD - Moldavia 2
MU - Mauritius 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
BB - Barbados 1
EE - Estonia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
Totale 15.946
Salva come PNG Salva come JPEG
Città #
Moscow 1.058
Dublin 804
Ashburn 740
Singapore 737
Chandler 547
Nyköping 433
Hong Kong 394
Dallas 360
Beijing 335
Messina 258
Jacksonville 229
San Jose 194
The Dalles 134
Princeton 127
Warsaw 122
Medford 114
Lauterbourg 110
Los Angeles 100
Des Moines 91
Dearborn 90
Cambridge 81
São Paulo 74
Ann Arbor 71
Ho Chi Minh City 71
Vienna 71
Buffalo 58
New York 55
Redondo Beach 51
Tianjin 48
Hanoi 45
Boardman 39
Frankfurt am Main 34
Santa Clara 34
Lancaster 33
Rio de Janeiro 33
Guangzhou 31
Munich 31
Jinan 30
San Mateo 30
Orem 26
Council Bluffs 25
Hyderabad 24
Montreal 24
Brussels 23
Belo Horizonte 22
Rome 21
Stockholm 21
Tashkent 21
Aversa 20
Curitiba 20
Amsterdam 18
Brooklyn 18
Chicago 18
Houston 18
Tokyo 18
Wilmington 18
Brasília 17
San Francisco 17
Baghdad 16
Campinas 16
Porto Alegre 16
Pune 16
Atlanta 15
Seattle 15
Shanghai 15
Shenzhen 15
Johannesburg 14
Mexico City 14
Milan 14
Shenyang 14
Chennai 13
Denver 13
London 13
Woodbridge 13
Boston 12
Düsseldorf 12
Montevideo 12
Montpellier 12
Mumbai 12
Casablanca 11
Taizhou 11
Augusta 10
Catania 10
Dong Ket 10
Guarulhos 10
Haikou 10
Helsinki 10
Nanjing 10
Nuremberg 10
Palermo 10
Phoenix 10
Uberlândia 10
Zhengzhou 10
Bari 9
Biên Hòa 9
Da Nang 9
Hebei 9
Manaus 9
Poplar 9
Ankara 8
Totale 8.782
Salva come PNG Salva come JPEG
Nome #
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 239
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 202
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 191
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 187
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 177
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 169
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 168
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 168
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 164
A novel benzodiazepine derivative that suppresses microtubule dynamics and impairs mitotic progression 162
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 160
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 160
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: Investigation of electronic effects 158
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 158
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 158
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 157
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 157
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 153
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: investigation of electronic effects 151
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 151
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 150
Design and synthesis of novel isoxazole-based HDAC inhibitors 150
Development of novel amides as non covalent inhibitors of immunoproteasome 150
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 147
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 147
Evaluation of curcumin irreversibility 146
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 145
Falcipain-2 inhibitors 144
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 144
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 143
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 140
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 140
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 140
Composti antitumorali 140
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 140
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 139
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 139
Role of the microbiota in hematologic malignancies. 138
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 136
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 136
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 135
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 134
Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications 133
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 131
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 130
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 130
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 128
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 127
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 126
Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives 125
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 124
Development of peptidomimetic boronates as proteasome inhibitors 123
A second opportunity for the peptide-based analogues with γ-lactam at the P1 position: human cathepsin S inhibition 123
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 122
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 121
Glutamate Binding-Site Ligands of NMDA Receptors 121
Development of peptidomimetic boronates as proteasome inhibitors 121
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 121
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 121
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 121
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 117
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 117
Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: The Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives 116
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 116
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 115
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 115
A proteomic platform unveils the brain glycogen phosphorylase as a potential metabolic target for glioblastoma multiforme 115
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 114
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 114
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 113
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 113
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 113
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 113
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 112
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 112
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 110
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 109
Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives 109
Development of nonpeptidic vinyl and allyl phosphonates as active-site-directed inhibitors of falcipain-2 108
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 108
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 107
Monoclonal antibodies: the greatest resource to treat multiple myeloma 107
Nonpeptidic Vinyl and Allyl Phosphonates as Falcipain-2 Inhibitors 106
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents 104
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 102
Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors 101
Synthesis of constrained dipeptide mimics containing the benzodiazepine scaffold 100
Identification of a new series of non-covalent proteasome inhibitors with selectivity for β5-subunits 100
Novel peptidomimetics containing a β-turn mimetic 1,4-Benzodiazepine scaffold as falcipain-2 inhibitors 99
Recent Advances in Nanotherapeutics for Multiple Myeloma 99
Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives 98
Synthesis of Peptidomimetics with the Benzodiazepine Nucleus as beta-turn mimic 98
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 97
Novel Peptidomimetics Containing a Vinyl Ester Moiety as Highly Potent and Selective Falcipain-2 Inhibitors 94
Novel peptidomimetic cysteine protease inhibitors as antimalarial agents 94
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 94
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 94
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 94
Mechanism and Site of Inhibition of AMPA Receptors: Substitution of One and Two Methyl groups at the 4-Aminophenyl Ring of 2,3-Benzodiazepine and Implications in the “E” Site 94
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 93
Totale 12.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022771 11 104 6 48 14 6 65 25 7 53 133 299
2022/20232.281 182 201 103 179 141 229 36 148 959 4 76 23
2023/2024589 69 72 41 143 55 48 6 8 3 62 33 49
2024/20252.463 41 21 44 157 92 56 75 460 676 175 236 430
2025/20268.329 306 531 538 656 689 1.792 1.082 1.054 1.018 366 134 163
Totale 16.523